Source: Abstracts. Conference titles: Oral Oncology Head and Neck Oncology & Pathology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, CARCINOMA DE CÉLULAS ESCAMOSAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNITCOVSKY, I. et al. Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. 2007, Anais.. Amsterdam: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 190. . Acesso em: 31 out. 2024.APA
Snitcovsky, I., Bruniati, K., Leitão, G., Pasini, F., Federico, M., Castro, G., et al. (2007). Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. In Abstracts (p. 190). Amsterdam: Faculdade de Medicina, Universidade de São Paulo.NLM
Snitcovsky I, Bruniati K, Leitão G, Pasini F, Federico M, Castro G, Carreiro K, Campoflorito C, Villar R, Mangone F, Maistro S. Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. Abstracts. 2007 ; 190.[citado 2024 out. 31 ]Vancouver
Snitcovsky I, Bruniati K, Leitão G, Pasini F, Federico M, Castro G, Carreiro K, Campoflorito C, Villar R, Mangone F, Maistro S. Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients. Abstracts. 2007 ; 190.[citado 2024 out. 31 ]
